Copeptin (Vasopressin) is a new diagnostic parameter that – together with a Troponin test and other clinic findings – allow for the early rule out of acute myocardial infarction (AMI) in patients with chest pain. Patients negative for both markers can be directed towards the appropriate care pathway:
- At initial presentation
- Without serial blood sampling
- With a NPV (Negative predictive value) of 99.7%
Make the right decision on treatment and patient management!